Clinical Trial

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

Recruiting
View on ClinicalTrials.gov →
Summary
This study assesses how blood cell growth patterns (clonal hematopoiesis) relate to heart health or cardiovascular disease (CVD) after treatment in patients with Hodgkin lymphoma. In some patients, cancer treatment at a young age may lead to later complications, including problems with heart health. Checking for blood cell growth patterns called therapy-related clonal hematopoiesis (t-CH) can help predict who might be at risk for heart health problems after Hodgkin lymphoma treatment. If doctors know who may be at greater risk for developing later heart complications, then they can more closely monitor those patients to prevent or detect heart complications early.
Protocol Amendment History 2 changes
notable Trial sites expanded: 32 -> 36 locations 2026-07-31
notable Trial sites expanded: 29 -> 32 locations 2026-05-06
Trial Details
NCT Number NCT05705531
Lead Sponsor Children's Oncology Group
Conditions Cardiovascular Disorder, Classic Hodgkin Lymphoma, Clonal Hematopoiesis
Enrollment 190 participants
Start Date 2023-08-18
Primary Completion 2028-10-01 (estimated)
Study Completion 2028-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-30